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 Abstract 
Biomolecular structure modeling remains one of the most compound and challenging 
tasks in molecular biology. One of the techniques used to meet this challenge is 
homology modeling, which aids in predicting the 3D details of unknown biomolecular 
structures, relying heavily on resources such as sequence-structure information and 
prototype-function relationship. Three dimensional models of Dengue Envelope and 
NS3 proteins were created. Ramachandran plot was used to verify the correctness of 
the models in terms of geometry and root-mean-square deviation from PDB templates. 
The present work provides an insight into the determination of the three dimensional 
structures of the envelope and NS3 proteins of seven dengue viruses isolated in 
Singapore and correlation of their three dimensional structures with experimentally 
available antigenic data. The residues essential for the function of these proteins can 
be known and this may serve as a guide for further investigation on these proteins. 
The amino acid residues in the dengue viral proteins important for the interaction with 
inhibitors have also been highlighted. Potential chemical compounds which might 
serve as Dengue inhibitors were docked with these proteins, and this information may 
pave the way for the design of new anti-dengue drugs thereby aiding the discovery of 
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 Chapter 1: Introduction 
Proteins are indispensable chemical components of all living things. They are 
complex structures formed from aminoacids and exhibit wide functional abilities. In 
the last two decades, structural studies on bio-molecules have played a very important 
role in the biological world. In order to explain a biological function, it is mandatory 
to include the shape of the bio-molecules involved. Hence, bimolecular structure 
modeling remains one of the most complex and challenging tasks in molecular 
biology. Homology modeling is one of the techniques used to meet this challenge. 
The aim of Homology modeling is to predict the 3D details of unknown biomolecules 
with the aid of various software tools. The large gap between primary sequences and 
three-dimensional structure of proteins can be bridged by the homology modeling 
technique. The models thus obtained can be docked with several rationally designed 
ligands which might lead to the discovery of novel protein inhibitors. 
 
1.1 Bioinformatics 
Bioinformatics is a newly developed interdisciplinary research area lying at the 
interface of chemical, biological and computational sciences. It can be used to solve 
biological problems and for gaining an understanding of the molecular basis of 
biological phenomena. The information so obtained is used in analyzing protein 
behaviors, designing experiments to know the relationship between structure and 
function, obtaining detailed understanding of molecular processes and developing 
drugs based on chemical similarity of known drugs. Certain processes in drug 
development such as Lead identification, Quantitative Structure Activity Relationship 
(QSAR), etc. for the development of new potent drugs can be done easily via the 
available bioinformatics tools which is highly cost-effective and eco-friendly. 
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 1.1.1 Biological data 
There is a huge library of data collected from biological sources. Managing these fast-
growing data is very difficult and hence nowadays they are being stored and 
exchanged in digital form as files or databases. Some primary nucleotide sequence 
databases are the DDBJ, EMBL nucleotide database and the GenBank. Ensembl is a 
well known genome database. Renowned protein sequence databases are the Uniprot, 
Swiss-prot and the PIR. Protein structure databases include the PDB, CATH, SCOP, 
Swiss-Model and the ModBase.  
 
1.1.2 Applications of bioinformatics 
Sequence alignment, genome assembly, protein sequence alignment, protein structure 
prediction and studying protein-protein interactions are the major fields involved in 
bioinformatics. Phylogenetic trees can be constructed and used to determine the 
relations between species. Genome annotation (marking of genes in a DNA sequence) 
and analysis of High throughput mass spectrometry and protein microarrays can be 
done using the bioinformatics approach.  
Another important application of bioinformatics is protein structure prediction. 
Computer simulations of cellular systems can be done to analyze and visualize the 
complex connections between cellular processes. The protein-protein interactions 
based on 3D structures of proteins can be predicted without performing wet lab 
experiments.  
 
1.2 Structure based drug design and prediction of protein structure 
The Swissprot database consists of about 356194 protein sequences as of March 2008. 
In contrast, the RCSB PDB has only 49295 protein structures deposited for the same 
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 date. There is a rapid increase in the discovery of new protein sequences with 
unknown structures as compared to experimentally determined structures (Fig. 1.1). 
This is due to the difficulties faced in the experimental methods such as the 
crystallization and phase problems in XRD and resolution problems in NMR. 












 Structures in PDB
 Sequences in Swissprot
 
Fig 1.1: Plot of the annual distribution of number of protein sequences in SWISS-
PROT and protein structures in the PDB1  
 
Structure based drug design requires considerable knowledge of the three-dimensional 
structure of the receptor protein. A lead structure can be designed rationally; its 
binding with the receptor can be analyzed deeply and if significant drug-like 
properties are identified, it can be experimentally synthesized and studied further. If 
the structure of the receptor protein (target) is unknown, there are two possible 
methodologies that can be followed for the discovery of new novel drugs.   
• Three dimensional QSAR model can be established based on a known set of 
ligands thereby extracting the 3D features based on the known trends in 
binding affinity. 
• Homology modeling can be used wherein a model of the target protein can be 
constructed and it can be docked with several ligands. 
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 1.2.1 Homology modeling in Bioinformatics Age 
In homology modeling, the computer is used as an experimental tool to predict the 3D 
structure of an unknown protein from its aminoacid sequence. The basis of this is to 
build suitable models that will presumably closely resemble the unknown protein and 
to evaluate the quality of the models and choose the best one amongst the built 
models. 
Homology means ancestral relationships, and assumes that proteins from the same 
families share folding motifs even if they don’t share the same sequences2. The 
models are based on known protein structures (templates) which resemble the 
unknown amino acid sequence. Protein structures are more conserved than protein 
sequences and hence noticeable levels of sequence similarity usually implies 
significant structural similarity3. The sequence alignment and template structures 
determine the quality of the model thus produced. Complications during model 
building are usually caused by the structure gaps (missing aminoacid residues) present 
in the template which arise from poor resolution in NMR and XRD experiments. A 
decrease in sequence identity lowers the quality of the model.  There is a twilight zone 
limit of sequence identity between the template and target protein at which point the 
homologous template backbone is no longer sufficient to constrain the correct packing 
of the buried side chains4. 
Homology models can be used to formulate hypotheses about the structure 
biochemistry of the query sequence but they have to be accompanied with 
experimental results in order to prove such hypotheses. Critical Assessment of 
Techniques for Protein Structure Prediction (CASP) is a biannual large-scale 
experiment which is used to assess the accuracy of models built by this technique. 
The basis for homology modeling is the Protein Data Bank (PDB) that contains 3D 
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 structures of proteins determined by experimental methods such as XRD and NMR. 
Some of the fundamental concepts of bioinformatics and computational chemistry 
have been summarized in this chapter. Detailed information can be obtained in the 
following references. (5-6)  
The most favourable situation in structure based drug design comprises the access to 
multiple crystal structures of the target binding studies, with and without ligands 
being bound to it. To be able to describe systems in which no crystal information is 
available, homology models can be built. The general procedure for homology 
modeling is: 
1. search for crystal templates of high similarity and high evolutionary relationship 
with regard to secondary structure and three dimensional correspondence. 
2. align the sequence of the desired protein to the crystal structure sequence 
3. build homology models using a comparative modeling software 
4. evaluate the models of the basis of stereochemistry parameters. 
In general, the models should be based on templates with as high sequence similarity 
and conserved secondary structure as possible. Templates with 30% sequence 
similarly have been named as a lower limit for reasonable accuracy in the final model. 
It is generally accepted that the higher the sequence identity between the template and 
the target, the better will the model turn out. 
1.2.2 Applications of Homology modeling 
Various applications of homology modeling include: 
• Structure based assessment of target drugability 
• Structure guided design of mutagenesis experiments 
• Tool compound design for probing biological function 
• Homology model based ligand design 
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 • Design of invitro test assays 
• Structure based prediction of drug metabolism and toxicity 
• Design of mutants to test hypothesis about a protein’s function 
• Identify active and binding sites 
• Modeling substrate specificity 
• Protein-protein docking 
 
1.2.3 Major steps involved in homology modeling 
There are four main steps involved in the technique of homology modeling. They are: 
 Target identification 
Initially, the amino acid sequence of a protein whose structure is unknown should be 
identified. The target sequence should be of biological significance. 
 Template selection 
Template selection is a critical step since the correctness of the model depends largely 
on the templates chosen. This can be done by a pair wise sequence alignment via 
database search techniques such as FASTA7 and BLAST8. Multiple sequence 
alignment via the PSI BLAST9 can be used if many templates are chosen. The 
traditional homology modeling methods used protein threading for template 
identification. Threading involves determination of the special and chemical similarity 
between the target and template by aligning the target sequence with the 3D structure 
of a template. During a BLAST search, hits with low E-values are considered to be 
suitable for use as templates. 
 Target-template alignment 
The amino acid sequence of the target has to be aligned with that of the template in 
order to group the conserved regions in the target and template so that they can be 
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 aligned in the same 3D orientation. The most commonly used software for the 
sequence alignment is ClustalX10. 
Mapping sequence onto template 
The coordinates of the structurally conserved regions (SCRs) from the template(s) are 
then transferred to the target.  
Model Construction 
Once the alignment is done, a three-dimensional structural model of the target has to 
be generated which can be represented as a set of Cartesian coordinates for each atom 
in the protein. There are software available for this purpose of which, the Swisspdb(11, 
12) and Modeller(13, 14) are the most commonly used. The variable regions such as the 
loops and side chains are then modeled by incorporating appropriate insertions and 
deletions. The free energy of the model is then minimized by software such as 
CHARMM15. 
Model assessment and Evaluation 
It is important to assess the validity of the built protein model once it is constructed. 
There are several approaches to evaluate the quality of the protein models. The most 
popular one is the protein model analysis by examination of the structure and studying 
its deviation from the norm (by drawing the Ramachandran plot). 
The model can be assessed preliminarily by its RMSD deviation from the template. If 
the RMSD deviation is minimal, then it is more likely that the model is an accurate 
prediction of the actual structure of the target. However, the accuracy of protein 
structure modeling is limited by the resolution of the NMR and X-ray crystallography 
data of the protein structure templates.  
Extensive model validation reports can be obtained using the WHATCHECK16 and 
PROCHECK17 software which assess the stereo chemical quality of a protein 
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 structure. They compare the geometry of the model residues with the stereo chemical 
parameters obtained from high resolution crystal structures. 
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Fig 1 .2: Flowchart showing the homology modeling steps 
 
1.2.4 Modeller (13, 14) 
The most commonly used software for homology modeling is the Modeller which 
enables the theoretical prediction of the 3D structure of a protein from its sequence. 
This program does 3D comparative modeling based on sequence alignment of 
templates to target sequences. The alignment can be done outside MODELLER 
in programs such as ClustalX which facilitates two dimensional alignment based 
on amino acid sequence similarity. The alignment must be checked carefully to 
avoid gaps in secondary structure elements. When the alignment is satisfactory, 
it is used for modeling in MODELLER. The algorithm is based on extracting and 
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 retaining spatial restraints such as bond lengths, bond angles, dihedral angles, free 
energy associated with various molecular geometries etc. Here the target protein 
sequence is first aligned with the sequence of proteins with known 3D structures 
(template proteins). The residue conformation is restrained based on the residue type 
and similarity between the target and template. Each of these restraints is portrayed as 
probability density functions which are then combined with a CHARMM force field 
to enforce proper stereochemistry of the residues. 
Models with different structures can be obtained wherein the target protein will 
exhibit conformational flexibility in the regions devoid of sequence similarity. 
Modeller has a major advantage in that restraints derived from several other sources 
(according to our requirement such as those in terms of secondary structure packing, 
hydrophobicity analyses etc) can be added to the homology-derived restraints. Thus, a 
model built using Modeller can be improved to a greater extent by combining the 
available experimental data with our knowledge about the target protein structure. We 
can also incorporate certain ligand binding properties also if we have a prenotion of 
the binding sites in the target. 
Modeller has an inbuilt energy minimization program for the models being built. The 
various model evaluation scores in Modeller are the following: 
• Molpdf (objective function) score: 
MODELLER currently implements a conjugate gradients algorithm and a 
molecular dynamics procedure. The molecular dynamics procedure is used in a 
simulated annealing protocol. 
Molecular Dynamics: 
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 In molecular dynamics simulations, energy is added to a system as 
kinetic energy related to the temperature of the system. Under these 
conditions, molecules can overcome conformational barriers.  
• DOPE (Discrete Optimized Protein Energy) assessment score: 
DOPE is a statistical potential used to assess homology models in protein 
structure prediction. It is used to assess the energy of the protein model generated 
through much iteration by MODELLER, which produces homology models by the 
satisfaction of spatial restraints. The models returning the minimum molpdfs can 
be chosen as best probable structures and can be further used for evaluating with 
the DOPE score. The DOPE method is generally used to assess the quality of a 
structure model as a whole.  
• GA341 assessment score: 
The GA341 score ranges from 0 for models that tend to have an incorrect 
fold to 1 for models that tend to be comparable to at least low-resolution x-ray 
structures. GA341 scores greater than 0.7 indicate a correct fold. 
 
1.3 Pharmacophore modeling 
A pharmacophore corresponds to those features common to a set of compounds, 
acting at the same receptor site, which are responsible for recognition and activation.  
Common pharmacophoric features are hydrogen bonding sites and hydrophobic 
regions. Atoms that can behave as hydrogen bond acceptors are, for example, 
carbonyl oxygen atoms and Donors could be hydroxyl or an amide NH group. One 
fundamental assumption in drug design is that similar molecules can be expected to 
exhibit similar biological activity. Substituents of groups that produce broadly similar 
biological properties and facilitate the safe interactions are called bioisosteric groups. 
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 Such groups are therefore often interchangeable in drug design, and they are used to 
maintain receptor interactions but to change other properties thus enabling a most 
straightforward synthesis or avoiding toxic metabolites.  
 
1.3.1 Prediction of Protein Ligand Interactions 
The most important step in the computer-aided drug design is the design of suitable 
lead-like ligands; analysis of protein-ligand binding interactions (docking) and the 
identification of active binding sites in the target protein. The general idea of a 
docking program is to position the ligand in possible binding modes in the 
protein active site and to calculate a score for the protein-ligand complex.  
Ligand Docking 
The aim of docking is to predict the structure of the complex formed between the 
target protein (receptor) and the ligand. It involves finding out the complex with the 
global minimum binding free energy for a ligand bound to the binding site of the 
receptor protein. The complexity of the docking process arises from the huge 
macromolecular nature of target protein and the occurrence of ligand binding in 
aqueous solutions. The presence of water will contribute to complexity in the nature 
and number of interactions involved in the binding of ligand with the target. 
 
1.3.2 Autodock(18,19) 
There are several software available for the docking process such as the FlexX, 
Autodock, Gemdock etc. The software Autodock4 has been used for studying the 
interactions between the target proteins and possible leads. Autodock can be used to 
dock a ligand with the receptor protein and study the interactions between them such 
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 as hydrogen bonds, hydrophobic interactions, hydrophilic interactions and Vander 
Waal’s interactions. 
From the crystal structures of one or more templates, several preliminary homology 
models of the receptor protein can be generated. Certain ligands co crystallized with 
the template proteins will give us an indication of the ligand binding pocket of our 
target protein molecule. Potential inhibitor ligands can be placed in the binding pocket 
and docked to the target receptor ligand binding pocket. The protein models, now 
containing the docked ligands are then scored and the ligand conformation with the 
best orientation and affinity with the binding pocket is chosen. 
Grids: 
Protein structures are represented as grids in Autodock wherein the binding pocket of 
the target protein is represented as an affinity grid that is demarked and calculated 
depending on each type of atom present in the ligand (C, N, H, O etc) as well as the 
electrostatic potential grid.  
The probe interaction energies are calculated at all grid lattice intersections and grid 
points throughout the xyz space. Positions far away from the molecule will generate 
small energies while positions intersecting the molecules will give large positive 
interactions because of strong repulsion forces. Modest negative energies correspond 
to points in the interatomic space that give favourable interactions between the probe 
and the molecule. The energy values define the contours of the interaction fields and 
can be visualized for each probe alone. 
The grid dimensions were adjusted to fully embed the ligand in its 
crystallographically determined binding mode with an additional margin of at least 
4Å. The ligands were then docked into the merged binding pockets using AutoDock 
4.0 after averaging the grid maps representing the potential energy using the clamped 
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 grid method as described by Osterberg et al20. The Lamarckian genetic algorithm was 
applied using the docking protocol as given by Sotriffer et al21. 
These grid maps are then used for the calculation of the binding energy between the 
ligand and protein during docking.  
Morris et al18 in 1998 found that the Lamarckian genetic algorithm is the most 
efficient and reliable strategy that includes an energy minimization technique. There 
are two approaches to docking namely: 
• Rigid docking  
Here the protein is treated as a rigid moiety which is a considerable 
simplification of the entire process. Its results cannot be considered 
reliable if the binding pocket is known to be flexible or if the target 
structure is a homology model. 
• Flexible docking 
In flexible docking, flexibility in the side chains of the target 
macromolecule is allowed. Hence various conformations of the ligand 
can bind to various possible conformations of the binding pocket in the 
target protein molecule. 
 
1.4 Objective of the present study 
Dengue virus consists of three main proteins namely the Envelope protein, Capsid 
protein and the NS3 protein, all of which can be targeted for the inhibition of the 
dengue virus. The present study involves an attempt to gain an understanding of the 
3D structure of the Envelope and NS3 dengue viral proteins isolated in Singapore, 
using molecular modeling techniques; identify potential inhibitors of these proteins 
and to study the interactions of the potential inhibitors and the receptor residues.  
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 Chapter 2: Architecture of Dengue Virus 
Flaviviridae are a family of around 66 viruses, of which most of them have been 
associated with human disease. The most well-known viruses of this family are the 
dengue fever virus, hepatitis C virus, yellow fever virus, West Nile virus and the 
Japanese encephalitis virus. The most important mosquito-borne pathogen amongst 
humans is the Dengue virus which is one of the most wide spreading diseases in the 
world and is increasingly prevalent in the Asian, African and American subcontinents 
including Singapore, with new mutants and strains coming up over the years. The 
geographical distribution of DENV is limited to tropical and subtropical regions 
where Aedes mosquitoes are present.22 (Fig 2.1).  
 
 
Fig 2.1: World distribution of Dengue23 
 
2.1 Dengue virus transmission 
Dengue fever is transmitted to humans predominantly by the mosquito Aedes aegypti 
and Aedes albopictus. Aedes aegypti originated in Africa and has spread throughout 
most of the world and can be found between 30 degrees north latitude and 20 degrees 
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 south latitude (24-25). The female mosquito26, has the ability to spread dengue virus to 
another host after feeding on an infected host or can transmit the virus 8-10 days after 
it has amplified in the salivary gland27. Once mosquitoes are infected with dengue 
virus, they have the ability to transmit the virus throughout their entire life. 
Transovarian transmission is possible for dengue virus-infected Aedes aegypti28. The 
strain of Aedes albopictus found in Europe is a cold-resistant strain, and it has been 
suggested that it may result in future dengue outbreaks29. The symptoms of this viral 
infection include fever, headache, joint and muscular pains, vomiting, diarrhea and 
rashes.  
 
2.2 Dengue Disease 
There are four main serotypes of the dengue virus namely DEN1, DEN2, DEN3 and 
DEN4 of which DEN2 and DEN3 were the strains responsible for the recent 2005 
outbreak of dengue virus in Singapore.  In the year 2005, as many as 13,984 dengue 
fever cases and 19 deaths were reported in Singapore. Moreover, severe forms of the 
dengue disease, called dengue hemorrhagic fever (DHF) and Dengue Shock 
Syndrome (DSS) have emerged recently, causing 500,000 cases worldwide each year. 
It is believed that DHF may result from sequential infection by different virus 
serotypes, in a process known as antibody mediated disease enhancement30 (ADE) 
which allows for increased uptake and virion replication during infection with a 
different strain. The immune system is unable to respond to the stronger infection by 
the second strain as a result of which the secondary infection becomes far more 
serious. Hence, it is very difficult to find a vaccine that would protect effectively 
against all four dengue serotypes.  
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 2.3 Virus structure and composition 
 
2.3.1 RNA  
Flaviviruses consist of a single stranded positive sense RNA genome that is 
approximately 11 kb in size. The viral genome is translated as a polyprotein in the 
cytoplasm. There are signal and stop-transfer sequences that direct the translocation of 
the polyprotein back and forth across the endoplasmic reticulum (ER) membrane. The 
polyprotein is subsequently co- and post-translationally modified by viral and host-
encoded proteases to produce three structural and seven nonstructural proteins. The 
mature virion contains three structural proteins: the capsid, C; a membrane associated 
protein (which is produced from the precursor prM), M; and the envelope protein, E. 
The nonstructural (NS) proteins include large, highly conserved proteins NS1, NS3, 
and NS5 and four small hydrophobic proteins NS2A, NS2B, NS4A, and NS4B (31-33). 







Fig 2.2: Flavivirus Genome Organization. Proteolytic sites by proteases from the host 
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 2.3.2 Structural proteins 
Capsid protein: 
The Dengue capsid protein has a molecular weight of about 13.5 kDa. It is highly 
basic, being rich in lysine and arginine residues and forms a structural component of 
the nucleocapsid34. The terminal hydrophobic signal sequence is cleaved by the viral 
NS2B-NS3 protease before virion assembly resulting in the mature form of DENV C 
protein (35, 36). The DENV C protein is necessary for encapsulation of the viral genome. 
Infected cells release subviral particles that do not contain either C or the viral 
genomic RNA, suggesting an important role for C in proper packaging of the 
infectious virion37.  
Recently, the structure of the DEN2V C dimer was elucidated by nuclear magnetic 
resonation (NMR) techniques (38, 39). Dengue capsid protein contains four alpha helices 
and forms a dimer in solution. DEN2V C protein exposes a hydrophobic domain at 
one side of the dimer where it is proposed to interact with the viral lipid bilayer, and a 
positively charged region on the opposing side that is thought to interact with the viral 
RNA.  
Cleavage by host signalase is responsible for severance of capsid protein and pre-
membrane protein, while cleavage adjacent to the C-terminal hydrophobic domain of 
the capsid protein by the viral NS3 protease is responsible for release of mature capsid 
protein40.  
Premembrane and Membrane protein: 
The prM protein is a glycoprotein that forms heterodimers with E protein on the 
intracellular immature virion surface. The dimerization of prM and E is assumed to 
prevent exposure of the fusion peptide within the cell. The prM protein contains a 
stop transfer sequence and a signal sequence in two transmembrane helices. The stop 
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 transfer sequence localizes both prM and E to the lumen of the Endoplasmic 
Recticulum. prM and E dimerize within the lumen of the ER upon cleavage by a host 
signalase. Upon maturation and release of the virion from the cell, the host enzyme, 
furin, mediates the cleavage of prM to produce M.  This process is essential for virus 
morphology, viral release, and viral infectivity as it releases E from prM. The E 
proteins then reorganize into homodimers. The mature virion has a smooth 
appearance compared to the immature virion which contains spikes on the surface. 
By using cryo-electron microscopy, premature viral particles containing pre-
membrane protein were observed as larger virions (~600 Å in diameter) containing 60 
spikes on the surface compared to the mature viral particle (of ~500 Å in diameter) 
with a smooth surface(32, 41). It is believed that the immature particles play a role in 
preventing premature activation of the fusogenic particle after exposure to acid pH 
and in facilitating virus release. 
 Envelope protein: 
 Dengue envelope protein with a molecular weight of 54.5 kDa is folded largely into 
beta-sheets and contain three distinctive domains: the N-terminus central domain 
(domain I); the fusion (or dimerization) domain that contains the fusion peptide 
(domain II); and the immunoglobulin (IgG) like domain (domain III) 42. The domain 
III is thought to bind to the cellular receptor43.  
Envelope protein appears to be a homodimer in solution and is located on the surface 
of the viral particle. There are two glycosylated asparagines on each dengue envelope 
subunit: Asparagine-153 on domain I and Asparagine-67 on domain II44. The 
mannose found at the glycosylated site appears to be important for viral entry through 
receptor binding45. Exposure of envelope protein dimers to low pH in early 
endosomes after viral uptake results in irreversible conformational change of envelope 
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 protein to a trimer conformation (46-49). The process of pH-triggered dimer-to-trimer 
transition is still not clear, but the crystallographic structure of liposome-associated 
envelope protein trimer has been resolved recently at high resolution (2.0 Å) 44. The 
crystallographic structures suggest that envelope proteins in the dimer form undergo a 
dramatic conformational change through the interdomain linkers that results in 
irreversible conversion of the dimer envelope protein to the homotrimer form. This 
pH-induced trimer formation is capable of destroying the tight packing on the outer 
virion surface. 
 
2.3.3 Nonstructural Proteins 
The seven nonstructural proteins, NSl, NS2A, NS2B, NS3, NS4A, NS4B, and NS5, 
are encoded in the 3' region of the viral genome (Fig 2.2). 
NS1 protein: 
The NS1 protein with molecular weight 38.7 kDa contains a signal sequence that is 
located in the carboxy terminus of the E protein and is inserted into the ER50. NS1 is 
posttranslationally cleaved from NS2A by an unknown ER-resident host protease51. 
NS1 is a glycoprotein that forms homodimers and interacts with membranes (52-54). 
Glycosylation of NS1 protein is important for its dimerization55.  NS1 has been shown 
to be involved in the early steps of flaviviral replication. It can be secreted from 
infected cells or localize to sites of RNA replication within the cell. Small amounts of 
the NS1 protein associate with the cell surface and are capable of signaling through a 
glycosyl-phosphatidylinositol (GPI) anchor in response to cross-linking by NS1-
specific antibodies (56-58). In addition NS1 is an essential component of the viral 
replicase59. NS1 has also been used for vaccine development due to its ability of 
induce a cytolytic immune response (60-62)  
                                                                                                                                      19
                                                                   
                                                                                                                                    
 NS2A and NS2B proteins: 
NS2A protein with a molecular weight of 20 kDa has been identified as a 
hydrophobic protein with several transmembrane domains and was found to be 
involved in proteolytic cleavage of NS1 at its carboxy terminus50.  
The NS2B protein associates with NS3 to form the viral protease. The NS2B-NS3 
protease mediates cleavage of the viral polyprotein at the NS2A/NS2B, NS2B/NS3, 
NS3/NS4A, NS4A/NS4B and NS4B/NS5 junctions (63-66). NS2B hydrophobic protein 
(14.5 KDa) is a cofactor for NS3 protease activity. Although NS3 has a protease 
activity even in the absence of NS2b, NS2b has been shown to be required for trans 
cleavage of a cloned polyprotein substrate67. 
NS3 protein: 
NS3 is a nonstructural protein with a molecular weight of 70 kDa. It is hydrophobic 
and performs many functions. It functions as a serine protease (68-70), RNA helicase71, 
nucleotide triphosphatase and RNA 5´- triphosphatase (72-74). The N-terminal sequence 
of NS3 shares homology with other trypsin-like serine proteases. Its activity has been 
demonstrated in vitro using various types of substrates (75, 76). The RNA helicase, 
nucleotide triphosphatase and RNA 5´-triphosphatase activities of full-length NS3 or 
its C-terminal region (residues 169-619), have also been demonstrated in vitro77 and 
are considered to be important for RNA replication and 5´-m7GpppN-capping activity. 
It is likely that flaviviruses encode their own capping enzyme since they replicate in 
the cytoplasm.  
The methyltransferase activity of dengue for capping may be provided by NS578, the 
RNA dependent RNA polymerase, which contains a methyltranserase domain. 
Previous studies have shown that the helicase and nucleoside triphosphatase activity 
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 of NS3 could be enhanced by the NS5 protein, the protease domain of NS3 and the 
presence of RNA(70, 79).  
NS4A and NS4B proteins: 
The small proteins NS4A and NS4B have not been studied extensively. NS4a and 
NS4b are both hydrophobic proteins whose functions are still not clear. It is suggested 
that NS4a and NS4b may be involved in viral replication80. A previous study in 
yellow fever virus has shown that the interaction of NS4a and NS1 is important for 
yellow fever virus replication81.  
NS5 protein: 
The NS5 protein whose molecular weight is around 150 kDa is the largest of the 
dengue proteins and is highly conserved among the flaviviruses82. NS5 has a RNA-
dependent RNA polymerase activity containing a Gly-Asp-Asp (GDD) domain. NS5 
was found to interact with NS3 to form a replication complex83. In addition, NS5 can 
stimulate the NTPase activity of NS3, which is necessary for unwinding of dsRNA 
substrates by helicase activity during viral replication80. 
RNA-dependent RNA polymerase activity of NS5 protein has been demonstrated in 
vitro using dengue infected insect cells or Vero cells expressing NS5 protein84 and 
Escherichia coli expressed NS573.  
 
2.4 Viral attachment and entry 
Dengue virus enters a cell through receptor-mediated endocytosis through binding of 
envelope proteins and receptors (85-90). After the interaction of envelope protein with 
the receptors, envelope protein undergoes conformational changes to allow the fusion 
of plasma membrane with dengue viral envelope in a pH-dependent manner. The 
virus entry can be blocked by using antibody against envelope protein (91-94), or using 
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 protease to remove the cell surface receptors104. Dengue virus can also attach to 
macrophage or monocyte cells mediated by reactive immunoglobulin G (IgG) binding 
to Fc-receptors (95-97). The cells bearing Fc-receptor normally produce higher number 
of virus when infected with dengue virus in the presence of serologically cross-
reactive but not neutralizing antisera. This immunological phenomenon is known as 
“antibody-dependent enhancement” and is thought to contribute to the pathogenesis of 
dengue hemorrhagic fever and dengue shock syndrome (98, 99) 
 
2.5 Dengue Viral Life-Cycle 
Infection of the host cell with flaviviruses occurs by receptor-mediated endocytosis 
into clarithin-coated pits (77, 100). Acidification of endosomes causes E protein 
rearrangement to form homotrimers on the surface of the virion. The E proteins in 
flaviviruses obtain their trimeric form after acidification and the fusion peptide is 
usually internally located. The fusion peptide within domain II of flaviviruses is 
exposed by receptor binding and low pH. The hinge between domains I and II 
presumably allow E to insert the fusion peptide into the host's lipid bilayer. Domain 
III is thought to fold back onto itself bringing the host bilayer and the viral bilayer 
into contact allowing hemifusion. The E proteins then form trimers on the virion 
surface. After the virion has fused with the host cell membrane, the nucleocapsid core 
is released into the cytoplasm of the cell (Fig 2.3).  
The C protein disassociates from the viral RNA and translation of the viral RNA is 
initiated. Following translation and processing of the viral proteins, the non structural 
proteins form a viral replicase and bind to the viral RNA, initiating replication of the 
viral genome.  
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Fig. 2.3: Dengue virus – Replication cycle43, 101 
 
Once the viral proteins are translated and the genome is replicated, the virion begins 
to assemble within the lumen of the ER. Immature viral particles are shuttled through 
the trans-golgi network (TGN). The immature virion contains a spiked surface which 
has been shown to be the prM protein capping the E protein. During exocytosis, furin 
protease cleaves prM to M releasing E. E then forms homodimers on the surface of 
the virion. The mature viral particle has been shown cryoelectromicroscopy to have a 
spikeless, smooth surface with sets of three parallel dimers containing E. Mature viral 
particles are exocytosed via secretory vesicles. 
 
2.6 Prevention and control 
Although dengue vaccine development began in the 1940s, there is still no effective 
dengue vaccine available. Dengue vaccine development focuses on development of a 
tetravalent dengue vaccine due to concerns about antibody-dependent enhancement, 
which is described as a form of enhanced virus uptake into macrophage cells through 
the binding of non-neutralizing antibody against another serotype of DEN. The 
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Anti-viral drugs under development against dengue mainly focus on antagonizing the 
activity of capping, helicase, protease, and RNA-dependent RNA polymerase (102, 103). 
Antisense oligos, such as morpholinos, have shown ability to inhibit dengue viral 
translation in BHK cell and viral replication in Vero cells (104, 105). Most of the non-
specific antiviral drugs, such as the use of mycophenolic acid as an 
immunosuppressant agent, have shown certain efficacy for inhibiting dengue virus 
replication in vitro and in cell culture system. Currently, dengue vaccine and antiviral 
treatments for dengue infection do not exist. Supportive care and hydration are the 
only treatments available for dengue virus infected patients especially for those who 
developed hypertension with dengue hemorrhagic fever. It is hoped that a detailed 
understanding of the dengue viral life cycle and viralhost infection will help to 
develop anti-viral drugs and vaccines in the future. 
 
2.8 Homology Modelling of Dengue proteins 
Knowledge of the structural information of the Dengue envelope proteins is required 
in order to gain an understanding of the entry of this virus into host cells and for the 
design of suitable inhibitors of this viral protein. In addition, the modeled structures 
would highlight possible regions of the E protein that can be targeted to block viral 
entry. The design of small molecules capable of inhibiting the viral replication is 
mandatory and they should be designed such that they display increased 
bioavailability. 
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 An understanding of the conformational details of viral proteins is important if 
specific information is to be used for drug design purposes. The different domains of 
the dengue virus adopt somewhat different rotation angles with respect to each other, 
disclosing a flexibility that is thought to be necessary for viral replication process. 
In flaviviruses, membrane fusion is the initial step during the entry of enveloped 
viruses into cells. The fusion protein is the Envelope glycoprotein which is the 
primary target for neutralization. The structure of Envelope proteins of Dengue virus 
has been studied extensively and was found to have three antigenic domains I, II and 
III. Potential target sites were identified in the non structural proteins as well. 
Dengue disease was first recognized a serious issue in the 1960s, in Singapore and in 
1969, a nationwide mosquito control program was established which included, 
mosquito source reduction, public health education and law enforcement measures. 
All the four serotypes were detected in Singapore. The dengue incidence was 
relatively low during 1974-1985 after which the number of people infected with this 
virus increased progressively. In 2005 alone, nearly 14,000 dengue cases were 
reported in Singapore of which, about 10% were imported from the neighbouring 
countries like Malaysia and Indonesia. Hence there is an urgent need for the discovery 
of new vaccines and inhibitors of this dreadful disease. 
For the purpose of structure-based drug design, seven dengue virus strains isolated in 
Singapore were chosen. Amongst these, all the strains include the envelope protein 
sequence while the NS3 sequences of only three strains have been deposited in the 
Swissprot. These unknown structures were modeled by homology modeling using the 
Modeller software and the target sites were identified. These sites were docked with 
suitable ligands and the interactions between the ligands and the receptor sites were 
analyzed. 
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 Chapter 3: Dengue Virus Envelope Proteins 
 
3.1 Introduction 
Dengue virus envelope protein mediates attachment and entry into host cells by 
membrane bound fusion with the cell membrane of the host. During the assembly of 
the virion, envelope proteins that are newly synthesized are directed to the 
endoplasmic reticulum and golgi apparatus where a preliminary folding and post-
transcriptional processing occurs. The envelope protein must undergo conformational 
rearrangements in order to enter into host cells via membrane fusion. The packing of 





Fig: 3.1: Packing of E proteins in mature dengue virion43, 108  
A. Three parallel dimers have been highlighted. Domains I, II and III are colored 
red, yellow and blue, respectively. The fusion peptide is green in color 
B. Ribbon diagram of a single dimer with the same color coding. Black arrows 
point to the kl β hairpin in each monomer where ligand can bind. 
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 Crystal structures are the most common source of structural information for drug 
design. If no experimentally determined structure is available, a homology model can 
be used for drug-design. The model has to be first checked for its stereo chemical 
qualities such as bond lengths, bond angles, planarity and packing as well as the 
number of residues in the favorable regions of the Ramachandran plot before it can be 
used for drug design. 
In structure-based drug design, a potential ligand binding site on the target molecule 
has to be identified at first. Ideally, the target site is a pocket that contains many 
potential hydrogen bond donors and acceptors as well as hydrophobic characteristics. 
This site can be an active site or a pocket necessary for the mechanism of action of the 
virus. Cocrystallization studies in which the target or template is crystallized with a 
small molecule can be invaluable for the identification of the target site in the protein 
macromolecule. 
There are several computer-aided approaches for drug design such as the virtual 
screening, denovo lead generation etc. If certain ligands are already known, they can 
be modified and may become lead compounds for curing viral infections. In this work, 
potential lead compounds were identified106 and they were docked with the various 
envelope proteins of Dengue virus found in Singapore. Dengue virus surface contains 
180 copies each of the envelope glycoprotein abbreviated as E and the membrane 
protein, abbreviated as M. The Dengue envelope proteins contain 495 amino acids 
and are responsible for the activation of membrane fusion. In the fusion process, the 
dimeric form of the envelope proteins reassociates to the trimeric form on exposure to 
an acidic pH. The fusion peptide gets exposed to the host cell membrane due to a 37º 
conformational rearrangement in the hinge region between domains I and II. The 
conformational change that occurs during this process is irreversible44 and fusion 
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 occurs followed by viral entry into the host cell. The residue site corresponding to 
Asn-153 is highly conserved amongst most of the flaviviruses while the Asn-67 
residue is unique to the Dengue virus. 
It has been found that the hinge region between domains I and II in the dengue 
envelope protein can be targeted for inhibiting dengue viral replication process. There 
is a ligand binding pocket in the hinge region between domains I and II and it could 
be a target site for the development of inhibitors that would disrupt the correct 
conformational changes required for entry of dengue virus into host cells. On 
comparing the prefusion (pdb code:1oke) structure containing the β-octyl glucoside 
ligand and the post fusion (pdb code:1ok8) crystal structures of Den2 envelope 
proteins, it can be seen that the major difference between them is the rearrangement of 
a beta hairpin strand (residues 268-280) and the new formation of a ligand binding 
pocket. During the crystallization process, the detergent β-N-octyl-glucoside occupied 
this pocket. The following figure is the superposition of the prefusion and post fusion 






Fig. 3.2: Superimposed Prefusion (1oke) and postfusion (1ok8) conformations of 
Dengue E proteins with a closeup view of the conformational change of the β hairpin 
Blue: 1oke_A; Red: 1ok8 
                                                                                                                                      28
                                                                   
                                                                                                                                    
 By docking the ligand binding pocket (enlarged in Fig. 1) with a suitable ligand, this 
conformational change that is mandatory for viral replication can be prevented 
thereby inhibiting the spread of the dengue disease. The 3D structure of the Singapore 
dengue virus envelope protein was determined to devise a therapeutic approach to 
counteract the spread of this disease. Structures of drugs bound to their targets are 
valuable in drug discovery, because they show exactly how the drug binds – which 
part of the protein binds, and even which individual amino acids bind. This 
information is useful if the drug needs to be modified to make it more effective. The 
dengue envelope proteins with bound ligands determined by X-ray crystallography 
were identified from the RCSB PDB database (http://www.rcsb.org/pdb/). The most 
suitable one amongst these is the 1oke structure containing a β-octyl glucoside ligand 
in its binding pocket.              
                                                                
3.2 Materials and Methods 
The Dengue virus Envelope proteins were identified from Expasy server 
(http://ca.expasy.org/sprot/). From the data thus obtained, the dengue viral strains 
isolated in Singapore were identified. The amino acid sequences of the target dengue 
envelope proteins isolated in Singapore were obtained from Expasy server. The 
following table 3.1 provides the list of dengue viruses found in Singapore along with 
their accession numbers in Expasy and Genbank servers. 
The envelope proteins containing the entire sequence were selected from the above 
table and the amino acid sequence of their envelope proteins was compiled. A 
multiple sequence alignment was done using ClustalX software (Fig. 3.4).  
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 Table 3.1: Dengue virus strains isolated in Singapore 





number components PDB 
1 1990 P33478, CAB58544  P33478 
C, PrM, E, NS1, 
NS2A, NS2B, NS3, 
NS4A, NS4B, NS5 
- 
1 1993 AY762084, AAV31421 Q5UCB9 polyprotein - 
1 1995 AAB03618 Q66470 NS3 - 
1 2001 BAC77215 Q7TGE7 envelope glycoprotein - 
2 -  AAB03620 Q66472 NS3  Fragment - 
2 -    AAQ57125, AY359463  Q6UVK5 envelope glycoprotein - 
2 1991 AAM75199 Q8JTJ1 envelope glycoprotein - 
2 1991 AAM75188 Q8JTK2 envelope glycoprotein - 
2 1997 AAQ04499 Q336H1 polyprotein fragment - 
3 2004  AY662691, AAT75224 Q6DLV0 polyprotein 
2J7WA,  
2J7UA 
3 1995 AY766104, AAV34603 Q5UB51 
C, PrM, E, NS1, 
NS2A, NS2B, NS3, 
NS4A, NS4B, NS5 
- 
4 1995 AY762085, AAV31422 Q5UCB8 
C, PrM, E, NS1, 
NS2A, NS2B, NS3, 
NS4A, NS4B, NS5 
- 
 
The Phylogenetic tree was drawn using PhyLip software 
(http://evolution.genetics.washington.edu/phylip.html) by using this multiple 
sequence alignment. The phylogenetic tree shows the evolutionary relationship 
between the 8 Singapore Dengue viruses. It can be seen that the four serotypes are 
grouped with each other. The Distance method approach is used for creating the 
phylogenetic tree. First, a distance matrix is calculated by Protdist program from the 
multiple sequence alignment. Distance methods summarize the differences between 
sequences by calculating a pairwise distance measure between all aligned sequences. 
The matrix is then transformed into a tree by the Neighbor program. The program 
Drawgram was used to draw a rooted tree. After the data analysis and tree-drawing, 
the validity of data is assessed by a bootstrap analysis. 
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Fig. 3.3: Phylogenetic tree of Singapore Dengue virus strains 
The above tree was obtained by working with a single alignment (the one that was 
created using ClustalX) and using it as input to protdist and neighbor to generate a 
phylogenetic tree. Now, a number of pseudo-alignments can be generated from the 
original alignment, by randomly selecting columns with replacement, after which a 
phylogenetic tree is generated for each pseudo-alignment. This re-sampling technique 
is called bootstrapping, which is used to test the reliability of the phylogenetic tree.  
In order to model the abovementioned proteins, homologous template structures were 
obtained from NCBI’s BLAST (http://www.ncbi.nlm.nih.gov/BLAST) which 
compares the target sequence with the database sequences using pair-wise sequence 
comparison.  
Templates were selected on the basis of the “e” values from the BLASTP results. 
Three templates were used to build each of the models namely, 1uzg, 1tg8 and 1oan 
since they were found to exhibit a very good sequence similarity with the target 
Singapore proteins. The structural coordinates for the three templates namely 1uzg, 
1tg8, 1oan and the pre-and post-fusion forms of the virus shown initially with pdb 
codes 1oke and 1ok8 were taken from the RCSB pdb database. A listing of these PDB 
files of the Dengue viral envelope proteins is provided in Table 3.2. 
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 The sequence alignment of the targets and templates was done using ClustalX and the 
output was drawn using ESpript107. 
 
Fig 3.4: Multiple sequence alignment. The residues colored in Red indicate identical 
residues and those residues with red letters means “conserved substitutions” or most 
chemically similar residues. The residues in black denote ‘non-conserved 
substitutions’ or residues that are chemically not similar. Blue column indicates that 
more than than 70 % of the residues are similar according to physico-chemical 
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name Organism Year Remarks 
Resolution 
Å References
1OAN Envelope Den-2 2003
Crystal structure 
with ligands NA 
and NAG 
2.75 Modis et al, 2003 
1UZG Envelope Den-3 2005
Crystal structure 
with ligands 
BMA, FUL and 
NAG 
3.5 Modis et al, 2005 




2.61 Zhang et al, 2004 
1OK8 Envelope Den-2 2004
Post fusion 
crystal structure 
with ligand CL 
and NAG 
2.00 Modis et al, 2004 




2.4 Modis et al, 2003 
 
In homology modeling, the models were built using the program Modeller. Five 
models were built for each of the Envelope proteins and the best model was chosen 
based on the molpdf and DOPE scores incorporated in the Modeller program. The 
model with the lowest DOPE and molpdf scores were chosen in each instance. 
The next step was the optimization of bond geometry and the removal of unfavorable 
non-bonded contacts. This process is termed as energy minimization and the number 
of minimization cycles should be kept at a minimum just sufficient to improve the 
stereochemistry of the model. This is because, excessive energy minimization will 
cause the model to deviate markedly from the original model, which is not suitable 
and should be avoided. 
The models were subjected to energy minimization using CHARMM component of 
the Discovery Studio module. The energy minimization was carried out using the 
following protocol: all hydrogen atoms were added to the protein; a charm forcefield 
was applied and subjected to 20 steps of conjugate gradient minimization iterations 
until the model acquired a negative energy value. The RMSD between the protein 
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 structures were obtained by Swissmodel. The models were evaluated in terms of 
stereo chemical qualities with the help of Ramachandran plots drawn using the 
PROCHECK software. This minimized structure, whose quality was evaluated with 
PROCHECK, was taken as the final model and was used for docking studies. As can 
be seen from the Ramachandran plots (Appendix), most of the residues in all the 
seven models were in the favorably allowed regions and there were only about 0.6% 
residues in the disfavored region. This implies that there is a very high probability of 
these homology models being correct. The correctness of the models was further 
verified by the G-factor and Verify3D program. 
The following table 3.3 summarizes the results of the seven homology models built  
using the Modeller program: 
 


































































82.2 66.2 -12275.4 -31.16 1.07 
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 The Ramachandran plots of all the seven models show that most of the residues are in 
the sterically allowed region. The few amino acids that are in the disallowed region 
belong to the loop regions corresponding to the structurally variable region.  
Table 3.4: Validation results of dengue envelope protein models 
 
                                 
Chi1-Chi2 










P33478 4 224 6 0 0 -.08 -.21 -.12 85.3 14.7 
Q5UB51 1 235 6 0 0 -0.4 -.15 -.08 93.2 6.8 
Q5UCB8 5 222 6 0 0 -.06 -.15 -.09 92.5 7.5 
Q6UVK5 
 
3 240 6 0 0 -.09 -.24 -.14 85.3 14.7 
Q7TGE7 
 
4 224 6 0 0 -.07 -.17 -.10 92.2 7.8 
Q8JTJ1 
 
2 240 6 0 0 -.05 -.17 -.09 94.9 5.1 
Q8JTK2 
 
5 239 6 0 0 -.04 -.20 -.10 90.8 9.2 
The validation results done in terms of RC plot, chi1-chi2 plots, main chain and side 
chain parameters, G-factors, M/c bond length, M/c bond angles (by PROCHECK in 
table 3.4) show that the models are good. 
Visualization of all the models shown in this report was done using the PyMOL118 
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Fig. 3.5: Structure of the Envelope protein Homology models coloured according to 
secondary structure 
 
Yang et al106 used the approach of virtual screening to identify suitable inhibitors and 
they have found that rolitetracycline and doxycycline exhibited inhibitory effects. 
Compound ZX-2401 has been shown to exhibit excellent inhibitory activity against 
dengue virus in culture studies with minimum cellular toxicity110. There are certain 
peptides that can act as inhibitors of the dengue virus and they are known as peptide 
inhibitors111 of the dengue virus. Peptides that mimic certain portions of the envelope 
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 proteins inhibit structural rearrangements of the envelope protein thereby preventing 
viral infection. The envelope glycoprotein is comprised of beta sheets and certain 
peptides can interfere with the dengue virus entry into the host cells. The inhibitory 
peptides can serve as lead compounds for the development of peptide drugs to act 
against the dengue virus. The peptide inhibitors form a stable complex through a 
series of hydrogen bonds and hydrophobic interactions with the protein atoms. 
Inhibitory effects of the peptide could be potentially improved by modifying the 
amino acid residue composition by using computational modeling analysis.  However, 
peptides have a significant limitation in their potential utility as drugs. The primary 
problem is that our body has natural enzymatic processes for the breakdown of 
peptides and proteins. Hence, they will have a short duration of action in vivo. 
Secondly, many peptides are too large to pass through the digestive tract into the 
blood and they will have solubility problems. This indicates that most peptides can be 
administered only by injection. Also, peptide inhibitors often lack desired specificity 
since they will interact with many enzymes in the bloodstream. 
Potential inhibitors of the dengue virus were identified and their three-dimensional 
structures were drawn using the program SYBYL 7.3109.  The molecules were first 
sketched on the screen, hydrogen atoms were added and then Gasteiger Marsili 
charges were added. The energy of the structures were minimized by subjecting them 
to 1000 iterations and the three dimensional structures thus obtained were saved as 
pdb files. Their structures are as shown below. The corresponding 2D structures were 
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 Table 3.5: Ligands for inhibiting Dengue envelope protein activity 
Inhibitor name 3D structure 2D structure 
Doxycycline 
































Docking studies were then carried out using the program AUTODOCK. The phases 
involved in this are target protein preparation, ligand preparation, molecular docking 
and post-docking analysis. The structural data of the protein and ligands have to be 
first formatted into acceptable forms for the docking process.  
The structure of the β-octyl glucoside binding pocket of the dengue envelope protein 
in its bound conformation was isolated from all the seven built models and used for 
the docking process inorder to minimize the runtime of the computational program 
and to reduce the complexity. This isolated region included all the residues present in 
the hydrophobic pocket.  
For the docking process, two files namely the grid parameter file and the docking 
parameter files were prepared. For the protein, only polar hydrogen atoms were added 
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 and the charges were assigned according to the Kollman united-atom method. The 
grid maps around the protein binding site were calculated using AUTOGRID 4 with 
90 X 78 X 82 points and a grid spacing of 0.375 Å. For the ligands all hydrogen 
atoms were added and Gasteiger-Huckel charges were calculated. The utility 
AutoTors was used to define the rotatable bonds in the ligands. Autodock docked 
each ligand against this binding cavity and ranked each ligand by the docked energy 
of the docking conformation. Ten docking orientations were calculated for each 
ligand and the most suitable orientation was chosen based on careful analysis of the 
interactions. According to the ranking of the conformations and the interactions 
between the ligands and the binding site residues, the best ligands were chosen. 
 
3.3 Results and Discussion 
Molecules which score reasonably well during docking studies are evaluated further 
before they are taken to the experimental stage. Drug design requires optimization of 
many properties like dissolution, absorption, metabolic stability, distribution, 
elimination, toxicological profile, cost economy, pharmaceutical properties, etc. One 
evaluation is to check whether they are likely to be orally bioavailable, using 
Lipinski’s rule of five, according to which, a good lead should have less than five 
hydrogen bond donors, less than ten hydrogen bond acceptors, a molecular weight 
less than 500 and a calculated log of the partition coefficient less than 5. All the 
ligands chosen for this study have a molecular weight between 400-600 daltons and 
they obey all the main rules of Lipinski.  
The partition coefficient value can be calculated only by experimental methods and so 
is not considered in this study. The structures of the envelope proteins isolated in 
Singapore have not yet been elucidated by X-ray crystallography or by any other 
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 experimental technique. In order to study the binding characteristics of the proteins, 
homology modeling was done based on known X-ray structures, the receptor site was 
identified and docked with suitable potential lead compounds. The binding pocket has 
a hydrophobic nature comprising of the residues 46-54, 127-138, 187-210 and 268-
283. The sequence alignment of this hydrophobic core for the seven target proteins is 
given below: 
 
Fig. 3.6: Sequence alignment of the hydrophobic pocket 
There are 61 residues lining the binding pocket and of them, 30 residues are strictly 
conserved, 24 residues are partly conserved and there is no strict conservation in the 
remaining seven residues. Majority of the 61 residues are hydrophobic in nature and 
these residues are responsible for the entry of the virus into the host cell. 
The locations of those residues in the crystal structure that might influence the 
membrane fusion process are shown below: 
 
Fig. 3.7: Docked conformation of β-octylglucoside in the binding pocket of 1oke. The 
residues affecting the pH threshold of fusion are indicated (oxygen-red, nitrogen-blue 
and carbon-pink) and the β-octylglucoside ligand is shown in green. The formation of 
the hydrogen bonds with Glu49 and Gln271 is shown by a blue dashed line. 
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 As shown in the figure, the ligand, β-octyl glucoside is docked in the hydrophobic 
pocket and is situated in the middle among Gly275, Lys128, Leu277, and Gln52. All 
the selected ligands, thought to be potential leads were able to dock in the pocket at 
various locations. The ligands doxycycline and rolitetracycline were docked on the 
outside of the binding pocket and they extended into the pocket. They caused steric 
hinderance due to their large structures and also interacted with the chosen residues 
via their functional groups. The interactions between the ligands and the receptor sites 
were studied using the program Ligplot112 which is a program for plotting protein-
ligand interactions. The interactions mediated by hydrogen bonds and hydrophobic 
contacts are shown. Hydrogen bonds are indicated by dashed lines between the atoms 
involved, while hydrophobic contacts are represented by an arc with spokes radiating 
towards the ligand atoms they contact. The HBPLUS113 program has been used for 
calculating hydrogen bonds and hydrophobic contacts for plotting by the LIGPLOT 
program. 
The following figure shows the hydrogen-bonding networks and orientations of the 
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 Q5UCB8 
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 Table 3.6: Binding energy of docked es of ligands and Dengue envelope proteins 
 










P33478 -6.40 -4.08 -3.14 
Q5UB51 -5.44 -3.58 -3.64 
Q5UCB8 -5.10 -3.09 -2.56 
Q6  -5UVK5 .31 -4.30 -3.12 
Q7TGE7 -6.04 -4.44 -4.22 
Q8JTJ1 -5.76 -3.41 -3.73 
Q8JTK2 -5.13 -4.63 -3.04 
 
The above figures show the hydrogen-bonding networks and orientations of the three 
ligands with regard to the binding site of all the seven envelope protein models. It can 
be seen that these compounds were docked in positions near the hydrophobic residues 
in the binding pocket and form hydrogen-bonding networks with various residues. 
These ligands bind to the surface of the binding pocket and extend their structures 
centrally into the pocket. From Table 3.6, we can see that the estimated free energy of 
binding is the lowest for Doxycycline when compared with the values obtained for 
Rolitetracycline and ZX2401. The uncertainties associated with the interaction 
between the primary binding residues of the dengue viral proteins and the amino acid 
189, Leu191, Asp192 and 
variants (like Asp and Glu) arising as a result of their variable protonation states and 
possible counter ions have been excluded in the binding energy calculation. 
The receptor site of P33478 formed 4 hydrogen bonds with all the three ligands. 
However, the hydrophobic interactions were stronger in the case of doxycycline 
ligand and hence, lower binding energy was observed. In P33478, four hydrogen 
bonds are observed between doxycycline and the Thr 
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 Phe193 residues. On the otherhand, Q5UB51 formed hydrogen bonds with 
doxycycline via the Ile268, Met205 and Ala203 residues.  
All the ligands formed hydrogen-bonding networks mainly with residues Thr 189, 
Gln271, Ile46, His282 and Phe279. Autodock yielded lower binding energies for the 
Doxycycline ligand than for the other two compounds. The energy minimization 
process, done using SYBYL7.3 also pointed out that doxycycline complex has lower 
energy than the other ligands. The hydrogen bonds provide strong attractive forces 
sufficient to stabilize the binding of doxycycline to the hydrophobic residues thereby 
preventing the conformational rearrangement necessary for dengue virus replication. 
 my opinion, if wetlab experiments were carried out, doxycycline would prove to be 
f the dengue virus than rolitetracycline and ZX2401. 
a 
In
a good inhibitor o
 
3.4 Conclusion 
Identification of ligands that can be developed into leads to block the function of 
dengue viral envelope proteins thereby preventing viral entry into host cells is a 
growing area of research in order to facilitate the complete eradication of this wide 
spreading disease. Here, the interactions between potential lead ligands and the target 
were studied in detail. In order to minimize the docking time, a small region around 
the chosen target site was isolated to serve as the target receptor. In this study, the 
hydrophobic detergent binding pocket situated between domains I and II of the 
envelope protein, reported by Modis et. al was chosen as the target site since it is 
involved in the pH induced conformational rearrangement that is mandatory for 
dengue viral entry into host cells. It was thought that certain ligands would be able to 
prevent the necessary conformational change if docked in this site of the envelope 
protein, thereby interrupting viral entry. Tetracycline derivatives that belong to 
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 group of antibiotics might become potential leads for drug design. They consist of a 
linear, fused tetracyclic ring skeleton to which many functional groups are bonded.  
The possibility of these ligands binding to a site other than the predicted location on 
the envelope protein is always there. In order to know for certain, the exact location of 
the ligands in the envelope protein, we have to co-crystallize the envelope protein 
with these compounds so that their exact docking locations can be identified with 
spect to the binding pocket. These compounds may serve as the basis for the 
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 Chapter 4: Dengue Virus NS3 Proteins 
 
4.1 Introduction 
Every step in the life cycle of the dengue virus is a potential target for inhibiting viral 
replication. However, only a few steps are suitable for drug development of which 
NS3 and NS5 are being targeted in recent times.  NS3 and NS5 proteins constitute 
protease, helicase and polymerase that are essential for dengue viral replication. NS5 
carries methyl transferase, an enzyme that puts a cap on the viral RNA to stabilize it. 
The structure and biochemical properties of the NS3 protease, NS3 helicase, NS5 
methyl transferase and NS5 polymerase are being studied extensively in order to 
probe possible sites that could be targeted for viral replication. Both the NS3 and NS5 
are mostly conserved across all four dengue serotypes. 
 
Fig. 4.1: Overall structure of the NS2B-NS3 protein from Den4119. Proteolytic sites 
by proteases from the host cell and by NS2B-NS3 are indicated with light and dark 
blue triangles, respectively. Evolutionarily conserved residues for NS3 enzymatic 
activities are indicated. 
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 NS3 proteins: 
Nonstructural protein 3 (NS3) is responsible for proteolysis of the dengue viral RNA 
polyprotein as well as carrying out various enzymatic reactions that are mandatory for 
replication of the Dengue virus. NS3 is made up of 616 aminoacids of which the first 
167 amino acids contain the protease domain and the remaining part contains the 
helicase domain, NTPase and an RTPase. In this work, we have studied the NS3 
protease protein. 
• NS3 protease: 
Polyprotein cleavage occurs with the help of NS3 serine protease alongwith 40 
residues from the NS2B protein that acts as cofactor. NS3 protease is active only 
when it is bound to the viral cofactor NS2B and its activity is mandatory for the 
formation of the mature non-structural proteins necessary for replication. Moreover, 
NS2B cofactor is thought to be involved in the proper folding of the protein. The C 
terminus of NS3 contains the domain necessary for ATP activity. Thus, the NS3 
protein is an important target for antiviral therapy (114-117). Recently, the 
crystallographic structure of the full NS3 protein fused to 18 residue NS2B cofactor 
was reported at 3.15 Å resolution. The catalytic pocket of the protein shows the 
presence of a serine protease catalytic triad comprising His51, Asp75 and Ser135. 
Potential lead-like compounds could be developed from the crystal structure of the 
NS3 protease complexed with the Mung bean bowman-birk inhibitor. We can design 
suitable compounds capable of being developed in to anti-viral drugs that target the 
NS2B-NS3 protease protein domain. 
• NS3 helicase: 
The function of the NS3 helicase is to unwind the double stranded nucleic acids 
during the replication of the viral RNA. Energy is necessary for this process and this 
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 energy is provided by the hydrolysis of ATP and this hydrolysis is performed by the 
NTPase of the NS3 helicase proteins. The NS3 domain is reported to start from 
residue 160 and comprises the full carboxy-terminus. NS3 is a component of the RNA 
replication process in dengue virus when it is complexed with NS5. Its complexation 
with NS5 depends on the phosphorylation state of NS5. Also, NS3 interacts with the 
stem loop of the RNA in the 3’ NTR which might play an essential role for the 
initiation of the negative strand RNA synthesis. 
Recently, Padmanabhan et al have identified inhibitors that bind into the P1 subpocket 
of the catalytic triad site of the NS3 protease. Although, these inhibitors have low 
potency and specificity, they may be lead compounds for the further exploration of 
dengue virus inhibitors. It has been shown that the structure of dengue NS3 protease 








Fig. 4.2: Dengue NS3 protease with catalytic triad of His51, Asp75 and Ser135. 
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4.2 Materials and Methods:  
The NS3 protein sequence is available for only three of the Singapore dengue strains 
namely P33478, Q5UB51 and Q5UCB8. The NS3 proteins sequences were obtained 
from the Swiss-Prot-TREMBL database. Homologous template structures were 
identified from NCBI’s BLAST. The templates, the crystal structure of dengue 
viruses (PDB codes: 2QEQ, 2V8O, 2BHR, 2VBC and 1YKS) were obtained from the 
RCSB PDB database (Table 4.1). 
Figure 4.3 shows the multiple sequence alignment of the three NS3 proteins and the 
five templates used for the homology modeling process.  




name Organism Year Remarks
Resolution 
ºA References 
2QEQ NS3 helicase Kunjin virus 2007 XRD structure 3.10 
Mastrangelo et 
al, 2007 




2007 XRD structure 1.90 
Mancini et al, 
2007 





2.80 Xu et al, 2005 
2VBC NS3 protease helicase Den-4 2008 
XRD 
structure 3.15 Luo et al, 2008 
1YKS NS3 helicase Yellow fever 2005 
XRD 
structure 1.80 Wu et al, 2005 
 
Model Building and Evaluation: 
The 3D models of the three Singapore NS3 proteins were built by MODELLER based 
on the abovementioned templates. Five models were built for each of the NS3 
proteins and the best model was chosen based on the molpdf and DOPE scores 
incorporated in the Modeller program. The model with the lowest DOPE and molpdf 
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Fig. 4.3 Multiple sequence alignment. Residues colored in Red are identical residues and those with red letters mean conserved substitutions. 
Residues in black denote non-conserved substitutions. Blue column indicates that more than 70 % of the residues are similar according to 
physico-chemical properties. Secondary structures are also indicated based on 2VBC_A template’s secondary structure. 
 
 
 The optimization of bond geometry and the removal of unfavorable non-bonded 
contacts were done in the energy minimization process and the number of 
minimization cycles was kept at a minimum just sufficient to improve the 
stereochemistry of the model. This is because, excessive energy minimization will 
cause the model to deviate markedly from the original model, which is not suitable 
and should be avoided. 
The models were subjected to energy minimization using CHARMM component of 
Discovery Studio module. Energy minimization was carried out using the following 
protocol: all hydrogen atoms were added to the protein; a charm forcefield was 
applied and subjected to 20 steps of conjugate gradient minimization iterations until 
the model acquired a negative energy value. The RMSD between the protein 
structures were obtained by Swissmodel. This minimized structure was evaluated with 
PROCHECK and was used for docking studies. 
The model was evaluated using the Ramachandran Plot (Appendix) of Procheck. To 
evaluate the validity of 2VBC, 1YKS, 2QEQ, 2V8O and 2BHR as structural 
templates for the modeling of the dengue NS3 proteins, the sequence homology of 
this multiple templates with the target was examined and is summarized in the 
following table along with the results obtained using Modeller software. In addition, it 
was observed that the catalytic triad comprising three residues is also conserved. As 
expected, it was found that the overall conformation of the models were structurally 
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Fig. 4.4: Homology models of Singapore NS3 proteins 
After model development, energy minimization was done to remove the geometrical 
strain for the modeled structures. Ramachandran plot of each minimized model 
showed that the backbone angles are in the allowed region, indicating that these initial 
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 models can be safely used for further studies (Appendix). There is no side chain in 
glycine and hence, it can adopt phi and psi angles in all the four quadrants of the 
Ramachandran plot. Therefore, with the exception of glycine, there are very few 
residues in the disallowed region in the Ramachandran plot for each of the energy 
minimized models. 
Table 4.3: Validation results of Dengue NS3 protein models 
                                 
Chi1-Chi2 











P33478 8 355 6 0 0 -0.01 -0.18 -0.07 78.8 21.3 
Q5UB51 8 360 6 0 0 -0.04 -0.31 -0.13 73.3 26.7 
Q5UCB8 5 357 6 0 0 -0.01 -0.2 -0.08 85.4 14.6 
Ganesh et al have reported five small molecular compounds with inhibitory activity 
against DEN2 NS2B:NS3 protease. These contain guanidino groups and compound 1 
was found to exhibit best inhibition against the dengue NS3 protease. 4-
hydroxypanduratin A, a cyclohexenyl chalcone derivative derived from Boesenbergia 
rotunda was found to exhibit good competitive inhibitory activities towards dengue 2 
NS3 protease119. Boesenbergia rotunda is a common spice belonging to a member of 
the ginger family. Some of the flavanoids and chalcones extracted from it have been 
shown to be pharmaceutically active. A class of N-t-Boc amino acid ester derivatives 
of isomannide has been identified as potential serine protease inhibitors. In this work, 
preliminary molecular modeling studies of the interactions between these potential 
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 Table 4.4: Ligands for inhibiting Dengue NS3 protein activity 
 
Inhibitor name 3D structure 2D structure 

















Two potential inhibitors of the dengue virus were identified and their three-
dimensional structures were drawn using the program SYBYL 7.3109.  The molecules 
were first sketched on the screen, hydrogen atoms were added and then Gasteiger 
Marsili charges were added. The energy of the structures were minimized by 
subjecting them to 1000 iterations and the three dimensional structures thus obtained 
were saved as pdb files. Their structures are as shown in Table 4.4. The corresponding 
2D structures were drawn using the chemdraw software. 
Docking studies were then carried out using the program AUTODOCK. The phases 
involved in this are target protein preparation, ligand preparation, molecular docking 
and post-docking analysis. The structural data of the protein and ligands have to be 
first formatted into acceptable forms for the docking process.  
The active site of the NS3 protease of the dengue virus was identified and the residues 
corresponding to this active site were isolated from all the three built NS3 models and 
used for the docking process in order to minimize the runtime of the computational 
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 program and to reduce the complexity. This isolated region included the catalytic triad 
as well.  
For the docking process, two files namely the grid parameter file and the docking 
parameter files were prepared. For the protein, only polar hydrogen atoms were added 
and the charges were assigned according to the Kollman united-atom method. The 
grid maps around the protein binding site were calculated using AUTOGRID 4 with 
116 X 92 X 102 points and a grid spacing of 0.375 Å. For the ligands all hydrogen 
atoms were added and Gasteiger-Huckel charges were calculated. The utility 
AutoTors was used to define the rotatable bonds in the ligands. Autodock docked 
each ligand against this binding cavity and ranked each ligand by the docked energy 
of the docking conformation. Ten docking orientations were calculated for each 
ligand and the most suitable orientation was chosen based on careful analysis of the 
interactions. According to the ranking of the conformations and the interactions 
between the ligands and the binding site residues, the best ligands were chosen. 
 
4.3 Results and Discussion 
One useful method to predict possible leads for inhibiting the NS3 serine protease is 
to use computational modeling to dock molecules into three-dimensional protein 
structures of targets. The compounds can be assessed by binding them into the 
catalytic pocket of the built homology models using docking software like 
AUTODOCK. This molecular algorithm generates the most complementary match 
between the ligand and the receptor site. The interactions ie, the hydrogen bonding 
and the non-bonded contacts between the two potential inhibitors and the receptor site 
of the three NS3 Serine protease models are shown in the figures below. Although 
P33478 forms five hydrogen bonds with compound 1 as compared to only four with 
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 compound 2, the binding energy is less in case of compound 2. Also, from the binding 
energy values listed in Table 4.5, it can be concluded that compound 2 has a higher 
probability of being developed into an inhibitor of the NS3 activity of the dengue 
virus. Compound 2 forms hydrogen bonding network with the residues Gln 149, Ile 
147, Trp 71 and Glu 104. By binding to these residues, these ligands might prevent 
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Table 4.5: Binding energy of docked complexes of ligands and Dengue NS3 proteins 
Models 
Free energy of binding  
with compound 1 
(kcal/mol) 
Free energy of binding 
with compound 2 
(kcal/mol) 
P33478 -4.61 -4.71 
Q5UB51 -3.55 -4.60 
Q5UCB8 -3.18 -3.83 
 
 
Compound 2, when docked into the active site of the NS3 protease, shows three 
hydrogen bond interactions with P33478. One hydrogen bond is between the 
backbond -NH group of Gln149 and one oxygen atom of the ligand (3.22 Å) and the 
second hydrogen bond correspond to that between the carboxyl oxygen of Gln 149 
and the same oxygen atom of the ligand (2.68 Å) and the third with the carboxyl 
oxygen of Glu 104(2.88 Å) and the final one with the carboxyl oxygen of residue 
Glu102 (3.04 Å).  The residues Ile 147, Val 129, Gly 106, Val 105 and Trp 71 provide 
certain interactions stabilizing the NS3 protease-compound complex. 
 
4.4 Conclusion 
As part our antidengue research work, we have studied the interactions between 
certain ligands capable of being converted into antiviral drugs and the active sites of 
the dengue viral proteins. Several potential inhibitors could be docked and analyzed 
and their invitro activity could be studied. A preliminary molecular modeling study 
has been attempted with chosen ligands from literature in order to study 
computationally, the interactions between the ligands and the dengue viral proteins. 
From this study, we conclude that the replication of dengue virus can very well be 
interrupted by suitable small molecule compounds as drugs targeting specific viral 
replication processes and viral proteins such as the envelope and NS3 protease. 
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